2007
Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance
Seifer DB, MacLaughlin DT. Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance. Fertility And Sterility 2007, 88: 539-546. PMID: 17559842, DOI: 10.1016/j.fertnstert.2007.02.014.Peer-Reviewed Original ResearchConceptsPolycystic ovarian diseaseMullerian Inhibiting SubstanceOvarian reserveOvulation inductionInhibiting SubstanceDiagnosis of PCODRisk of OHSSOvarian growth factorsWidespread clinical useOvarian hyperstimulationOvarian diseaseOvarian functionMEDLINE reviewClinical significanceIntracycle variabilityEarly markerClinical useConventional markersDiagnostic markerGrowth factorSpecific cutIntercycle variabilityDifferent assaysMarkersDiagnosis
1999
Infertility treatment and informed consent: current practices of reproductive endocrinologists.
Houmard BS, Seifer DB. Infertility treatment and informed consent: current practices of reproductive endocrinologists. Obstetrics And Gynecology 1999, 93: 252-7. PMID: 9932565, DOI: 10.1016/s0029-7844(98)00389-5.Peer-Reviewed Original ResearchMeSH KeywordsData CollectionFemaleHumansInfertility, FemaleInformed ConsentOvarian NeoplasmsOvulation InductionPractice Patterns, Physicians'ConceptsOvulation inductionCurrent practice patternsInfertility treatmentOvarian cancerReproductive endocrinologistsInformed consentIntrauterine inseminationPractice patternsMost physiciansBoard-certified reproductive endocrinologistsReproductive technologiesPatients of risksOvarian cancer riskLength of treatmentLogistic regression analysisMajority of physiciansAssisted Reproductive TechnologyInvasive therapyCancer riskVerbal consentPossible associationEndocrinologistsCancerPhysiciansCommon changes
1997
Multiple Immunoreactive Inhibin Proteins in Serum from Postmenopausal Women with Epithelial Ovarian Cancer
Lambert-Messerlian GM, Steinhoff M, Zheng W, Canick JA, Gajewski WH, Seifer DB, Schneyer AL. Multiple Immunoreactive Inhibin Proteins in Serum from Postmenopausal Women with Epithelial Ovarian Cancer. Gynecologic Oncology 1997, 65: 512-516. PMID: 9190984, DOI: 10.1006/gyno.1997.4719.Peer-Reviewed Original ResearchConceptsEpithelial ovarian cancerPostmenopausal womenCA 125Serum markersOvarian cancerAlpha-inhibin precursorsDimeric inhibin APro-alphaC levelsSerum of womenPreoperative serum levelsGood serum markerInhibin proteinPotential serum markerAlphaC inhibinTotal inhibinInhibin BInhibin secretionSerum levelsInhibin AInhibinNonspecific assaysEOC casesWomenCancerSerum
1988
Cytoreduction of ovarian cancer with the Cavitron ultrasonic surgical aspirator.
Adelson MD, Baggish MS, Seifer DB, Cassell SL, Thompson MA. Cytoreduction of ovarian cancer with the Cavitron ultrasonic surgical aspirator. Obstetrics And Gynecology 1988, 72: 140-3. PMID: 3380505.Peer-Reviewed Original ResearchConceptsCavitron Ultrasonic Surgical AspiratorUltrasonic surgical aspiratorSurgical techniqueSurgical aspiratorStage IIIC diseaseIntra-abdominal malignanciesStandard surgical techniqueIIIC diseaseVisceral resectionsSmall bowelMean ageSurgical timeOvarian cancerTumor removalCytoreductionResectionPatientsDiseaseAspiratorBowelAdnexaMalignancyOmentumInjuryUterus
1986
Malignant lymphoma arising within thyroid tissue in a mature cystic teratoma
Seifer D, Weiss L, Kempson R. Malignant lymphoma arising within thyroid tissue in a mature cystic teratoma. Cancer 1986, 58: 2459-2461. PMID: 3768840, DOI: 10.1002/1097-0142(19861201)58:11<2459::aid-cncr2820581118>3.0.co;2-y.Peer-Reviewed Original ResearchA critical reassessment of second‐look laparotomy in epithelial ovarian carcinoma
Miller D, Ballon S, Teng N, Seifer D, Soriero O. A critical reassessment of second‐look laparotomy in epithelial ovarian carcinoma. Cancer 1986, 57: 530-535. PMID: 3942985, DOI: 10.1002/1097-0142(19860201)57:3<530::aid-cncr2820570321>3.0.co;2-5.Peer-Reviewed Original ResearchMeSH KeywordsCarcinomaFemaleHumansLaparotomyMiddle AgedNeoplasm Recurrence, LocalNeoplasm StagingOvarian NeoplasmsPrognosisRegression AnalysisConceptsSecond-look laparotomyEpithelial ovarian carcinomaOvarian carcinomaPersistent tumorSecond-line salvage therapyMultivariate logistic regression analysisPersistent ovarian carcinomaComplete clinical responseComplete pathologic responseFirst-line chemotherapyFirst-line therapyEvidence of recurrenceLarge residual tumorRisk of recurrenceLogistic regression analysisDisease-free statusCurative intentSalvage therapyAdjunctive therapyClinical responsePathologic evidencePathologic responseMicroscopic diseaseResidual tumorGross tumor